The Supreme Court is considering a lawsuit meant to reverse the Food and Drug Administration’s approval of the abortion pill mifepristone. The case has major ramifications for abortion access, given that a majority of abortions are now performed via medication. It also could reshape the 2024 elections, in which abortion is expected to be a significant consideration for voters. The Washington Examiner is featuring a series of articles providing an in-depth look at the case and its implications. This first entry lays out the basic facts that the Supreme Court will consider.
The Supreme Court on Tuesday is slated to hear oral arguments regarding the Food and Drug Administration’s approval of the abortion pill mifepristone, the ruling on the case having a significant bearing on abortion access heading into the 2024 election.
The legal fight against mifepristone started
Read more…
